FGFR4 and CDKN2A

Number of citations of the paper that reports this interaction (PubMedID 28205554)
55

Data Source:
BioGRID (fluorescent resonance energy transfer)

		FGFR4	CDKN2A
Description		fibroblast growth factor receptor 4	cyclin dependent kinase inhibitor 2A
Image
GO Annotations	Cellular Component	Extracellular Region Endosome Endoplasmic Reticulum Golgi Apparatus Plasma Membrane Cell-cell Junction Membrane Transport Vesicle Receptor Complex	Nucleus Nucleoplasm Nucleolus Cytoplasm Mitochondrion Mitochondrial Matrix Cytosol Nuclear Body Protein-containing Complex Senescence-associated Heterochromatin Focus
	Molecular Function	Nucleotide Binding Protein Kinase Activity Protein Tyrosine Kinase Activity Transmembrane Receptor Protein Tyrosine Kinase Activity Fibroblast Growth Factor Receptor Activity Protein Binding ATP Binding Heparin Binding Kinase Activity Transferase Activity Fibroblast Growth Factor Binding	P53 Binding DNA Binding RNA Binding Cyclin-dependent Protein Serine/threonine Kinase Inhibitor Activity Protein Binding SUMO Transferase Activity Protein Kinase Binding NF-kappaB Binding Ligase Inhibitor Activity Ubiquitin-protein Transferase Inhibitor Activity RNA Polymerase II-specific DNA-binding Transcription Factor Binding MDM2/MDM4 Family Protein Binding Disordered Domain Specific Binding Ubiquitin Ligase Inhibitor Activity
	Biological Process	Positive Regulation Of Cell Population Proliferation Fibroblast Growth Factor Receptor Signaling Pathway Regulation Of Gene Expression Positive Regulation Of Gene Expression Regulation Of Extracellular Matrix Disassembly Cell Migration Peptidyl-tyrosine Phosphorylation Regulation Of Lipid Metabolic Process Glucose Homeostasis Cholesterol Homeostasis Positive Regulation Of Catalytic Activity Positive Regulation Of MAPK Cascade Positive Regulation Of Proteolysis Protein Autophosphorylation Phosphate Ion Homeostasis Positive Regulation Of ERK1 And ERK2 Cascade Regulation Of Bile Acid Biosynthetic Process Response To Bile Acid Positive Regulation Of DNA Biosynthetic Process	Negative Regulation Of Transcription By RNA Polymerase II Protein Polyubiquitination Autophagy Of Mitochondrion Negative Regulation Of Cell-matrix Adhesion RRNA Processing Apoptotic Process Ras Protein Signal Transduction Negative Regulation Of Cell Population Proliferation Epidermis Development RRNA Transcription Regulation Of Gene Expression Positive Regulation Of Gene Expression Protein Sumoylation Keratinocyte Differentiation Negative Regulation Of Cell Growth Nuclear Body Organization Negative Regulation Of B Cell Proliferation Regulation Of Protein Stability Protein Destabilization Negative Regulation Of Immature T Cell Proliferation In Thymus Positive Regulation Of Protein Sumoylation Mammary Gland Epithelial Cell Proliferation Negative Regulation Of Mammary Gland Epithelial Cell Proliferation Positive Regulation Of Smooth Muscle Cell Apoptotic Process Protein Localization To Nucleus Somatic Stem Cell Population Maintenance Glucose Homeostasis Positive Regulation Of Apoptotic Process Positive Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator Keratinocyte Proliferation Negative Regulation Of Cyclin-dependent Protein Serine/threonine Kinase Activity Negative Regulation Of Cell Cycle Negative Regulation Of DNA-templated Transcription Positive Regulation Of DNA-templated Transcription Positive Regulation Of Transcription By RNA Polymerase II Regulation Of Nucleocytoplasmic Transport Regulation Of Protein Export From Nucleus Somatic Stem Cell Division Protein Stabilization Regulation Of Cell Cycle Mitochondrial Depolarization Apoptotic Process Involved In Mammary Gland Involution Positive Regulation Of Apoptotic Process Involved In Mammary Gland Involution Cellular Response To Hydrogen Peroxide Protein K63-linked Ubiquitination Cellular Senescence Replicative Senescence Oncogene-induced Cell Senescence Apoptotic Signaling Pathway Positive Regulation Of Protein Localization To Nucleus Positive Regulation Of Signal Transduction By P53 Class Mediator Protein Localization To Nucleolus Negative Regulation Of Proteolysis Involved In Protein Catabolic Process Regulation Of Protein Targeting To Mitochondrion Negative Regulation Of Ubiquitin Protein Ligase Activity Amyloid Fibril Formation Regulation Of G1/S Transition Of Mitotic Cell Cycle Negative Regulation Of Ubiquitin-dependent Protein Catabolic Process Positive Regulation Of Macrophage Apoptotic Process Negative Regulation Of Protein Neddylation
Pathways		PI3K Cascade PIP3 activates AKT signaling betaKlotho-mediated ligand binding FGFR4 mutant receptor activation FGFR4 ligand binding and activation Constitutive Signaling by Aberrant PI3K in Cancer Phospholipase C-mediated cascade; FGFR4 FRS-mediated FGFR4 signaling SHC-mediated cascade:FGFR4 PI-3K cascade:FGFR4 Negative regulation of FGFR4 signaling Signaling by FGFR4 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	Oxidative Stress Induced Senescence Senescence-Associated Secretory Phenotype (SASP) Oncogene Induced Senescence Cyclin D associated events in G1 Transcriptional Regulation by VENTX Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 Regulation of MITF-M-dependent genes involved in cell cycle and proliferation Apoptotic factor-mediated response Oxidative Stress Induced Senescence Oncogene Induced Senescence SUMOylation of DNA damage response and repair proteins SUMOylation of transcription factors Regulation of TP53 Degradation Stabilization of p53 Regulation of RUNX3 expression and activity Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function Evasion of Oncogene Induced Senescence Due to p14ARF Defects Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects Nuclear events mediated by NFE2L2
Drugs		Heparin Ponatinib Lenvatinib Infigratinib Erdafitinib Pemigatinib Futibatinib
Diseases			Chronic myeloid leukemia (CML) Non-small cell lung cancer Malignant islet cell carcinoma Adult T-cell leukemia Esophageal cancer Glioma Pancreatic cancer Nasopharyngeal cancer Hepatocellular carcinoma Squamous cell carcinoma Penile cancer Oral cancer Malignant melanoma Burkitt lymphoma Gallbladder cancer Bladder cancer Laryngeal cancer Cholangiocarcinoma Malignant pleural mesothelioma Osteosarcoma Type II diabetes mellitus
GWAS		A body shape index ( 34021172) Activated partial thromboplastin time ( 22703881) Apolipoprotein A1 levels ( 32203549) Appendicular lean mass ( 33097823) Body fat distribution (arm fat ratio) ( 30664634) Body fat distribution (trunk fat ratio) ( 30664634) Circulating fibroblast growth factor 23 levels ( 30217807) Height ( 25282103 31562340 28552196) Hemoglobin levels ( 32327693) Hip circumference adjusted for BMI ( 34021172) Hip index ( 34021172) Hip shape (DXA scan) ( 30320955) Narrowest width of the femoral neck ( 30888730) Nonsyndromic cleft lip ( 31609978) Type 2 diabetes ( 30718926 32499647) Waist circumference adjusted for BMI (adjusted for smoking behaviour) ( 28443625) Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) ( 28448500) Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625) Waist circumference adjusted for BMI in active individuals ( 28448500) Waist circumference adjusted for BMI in non-smokers ( 28443625) Waist circumference adjusted for BMI in smokers ( 28443625) Waist circumference adjusted for body mass index ( 28448500 34021172 25673412) Waist-hip index ( 34021172) Waist-to-hip ratio adjusted for BMI ( 34021172 26426971) Waist-to-hip ratio adjusted for BMI (additive genetic model) ( 30778226) Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625) Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971) Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625) Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971) Waist-to-hip ratio adjusted for body mass index ( 25673412 26785701)	Abdominal aortic aneurysm ( 20622881) Acute lymphoblastic leukemia (childhood) ( 29348612) Acute lymphoblastic leukemia in childhood (B cell precursor) ( 29632299) B-cell acute lymphoblastic leukaemia ( 31767839) Basal cell carcinoma ( 25855136 24403052) Basophil count ( 32888494) Breast cancer ( 23535729 29059683 20453838) Coronary artery calcification ( 23561647) Coronary artery disease ( 29263402 26708285 21239051) Coronary heart disease ( 21971053 21378990 17554300) Coronary heart disease (SNP X SNP interaction) ( 21626137) Coronary heart disease x type 2 diabetes interaction ( 32541925) Endometrial cancer ( 30093612) Endometrial cancer (endometrioid histology) ( 30093612) Endometriosis ( 23104006) Eosinophil count ( 32888494) Esophageal squamous cell carcinoma ( 25129146) Fasting plasma glucose ( 25187374) Glioblastoma ( 28346443) Glioma ( 21531791 28346443 19578367) Inflammatory bowel disease ( 27569725) Intracranial aneurysm ( 18997786 20364137) Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy) ( 27418160) Lymphocyte count ( 27863252 32888494) Lymphocyte percentage of white cells ( 32888494) Mean corpuscular hemoglobin concentration ( 32888494) Mean spheric corpuscular volume ( 32888494) Melanoma ( 28212542 19578364 21983787) Monocyte count ( 27863252 32888494) Multiple myeloma ( 27363682) Myocardial infarction ( 17478679 26708285) Myocardial infarction (early onset) ( 19198609) Nasopharyngeal carcinoma ( 26545403) Neutrophil percentage of white cells ( 32888494) Non-glioblastoma glioma ( 28346443) Non-small cell lung cancer ( 31326317) Parental longevity (both parents in top 10%) ( 29227965) Parental longevity (father's age at death) ( 29227965) Platelet count ( 27863252 22139419 32888494) Plateletcrit ( 27863252 32888494) Red cell distribution width ( 32888494) Reticulocyte fraction of red cells ( 32888494) Spleen volume ( 34128465) Type 2 diabetes ( 23209189 17463246 17463248 17463249 18372903 19401414 20581827 21573907 30718926 23945395 24509480 26818947 26961502 27189021 32499647 29358691 30297969) Waist-hip index ( 34021172) Waist-to-hip ratio adjusted for BMI ( 34021172) White blood cell count ( 27863252 32888494)
Interacting Genes		82 interacting genes: ABCB5 AKT1 ANGPTL4 ARAF ARNT BECN1 BLID CASC3 CBLC CCND2 CCNE1 CD44 CDH2 CDK4 CDK6 CDKN2A CDKN2B CDKN2C DIRAS3 EPHA4 EPSTI1 ERBB2 ERRFI1 FGF1 FGF17 FGF18 FGF19 FGF2 FGF3 FGF4 FGF5 FGF6 FGF7 FGF8 FGF9 FZR1 GLCE GLIS2 GRM1 HGF HIF1A IGF1R KDELR2 LATS2 LRATD2 MAP2K5 MAP2K6 MAP3K5 MAPK14 MDM4 MET MSH2 MTA3 MYC NF2 NSD3 OSGIN1 PDLIM2 PLCG1 PPP3CA PSMC3IP PTPN11 PTPN12 PTPN6 PTPRR RAF1 RASL10B RASSF1 RNF20 ROS1 SCGB3A1 SNCA STAT1 STAT3 STK11 TEAD2 TERT THRSP TP53 TSC1 TTYH2 WIF1	168 interacting genes: - ACLY ACTB ACTG1 ACTN4 AHNAK AKT1 ALDOB ANAPC15 ANGPTL4 ANKRA2 ANKRD12 AOPEP ARFIP2 ARNT ASPRV1 AZIN1 BAAT BCL2L1 BECN1 CARF CASC3 CCDC180 CCDC183 CCND2 CCNDBP1 CCNE1 CCNG1 CD44 CDC14B CDC42 CDC45 CDC5L CDC6 CDC7 CDK4 CDK6 CDKN2AIP CDKN2C CENPA CRELD2 CTBP2 CTSV CYLC2 DEAF1 E2F1 E4F1 EEF2 EFHC2 EGR1 EPHA2 EPHA3 EXOC2 FGFR4 FN1 FRAT2 GALNT12 GAPDH GGA1 GGA3 GLIS1 GLIS2 GMNN GSPT1 H2BC26 HGF HIF1A HLA-DOB HNRNPA2B1 HNRNPC HNRNPU HRAS HSP90AA1 HSP90AB1 HSPA4 HSPA8 HUWE1 ISOC2 KAT5 LATS2 MAF1 MAP2K1 MAP2K5 MAP3K5 MAPK10 MAPK14 MAPK3 MAPK8 MCM10 MCM2 MCM5 MCM6 MDM2 MDM4 MKRN1 MMRN1 MTR MYC MYL12A NAT2 NCL NMI NOP53 NPM1 NSD3 ORC4 PCNA PDCD6 PDGFRA PEX19 PPP1R9B PRKCA PSMC3 PTP4A3 RAF1 RASA1 RASSF1 RBM26 RIN2 RPL11 RPS7 RUVBL2 SEC61B SERTAD1 SFRP4 SGK1 SIVA1 SIX2 SLC4A1 SMARCA4 SNRPA SNRPB SOX3 SOX4 STK11 TBRG1 TDRD7 TEAD2 TERT TFDP1 TGFB1 TMEFF1 TMOD1 TP63 TPI1 TRIM28 TRIP12 TSC1 TUBA1A TUBA1C TUBB TUBB4B UBC UBE2A UBE4B UBL7 USP26 VAMP1 VHL WRN YY1 ZFP91 ZGRF1 ZNF227 ZNF410 ZNF420 ZNF687 ZUP1
Entrez ID		2264	1029
HPRD ID		00625	02542
Ensembl ID		ENSG00000160867	ENSG00000147889
Uniprot IDs		B4DVP5 J3KPQ0 P22455	K7PML8 P42771 Q8N726
PDB IDs		4QQ5 4QQC 4QQJ 4QQT 4QRC 4R6V 4TYE 4TYG 4TYI 4TYJ 4UXQ 4XCU 5JKG 5NUD 5NWZ 5XFF 5XFJ 6IUO 6IUP 6J6Y 6JPE 6JPJ 6NVG 6NVH 6NVI 6NVJ 6NVK 6V9C 6YI8 7DTZ 7F3M 7N1J 7TYD 7V29 7VJL 7WCT 7WCW 7WCX 7YBO 7YBP 7YBX 7YC1 7YC3 7YSW 8KH6 8KH7 8KH8 8KH9 8W5C 8XLQ	1A5E 1BI7 1DC2 2A5E 7OZT
Enriched GO Terms of Interacting Partners?		Regulation Of Cell Population Proliferation Cell Surface Receptor Protein Tyrosine Kinase Signaling Pathway Positive Regulation Of Cell Population Proliferation Enzyme-linked Receptor Protein Signaling Pathway Regulation Of Intracellular Signal Transduction Regulation Of MAPK Cascade Regulation Of Signal Transduction Fibroblast Growth Factor Receptor Signaling Pathway Signal Transduction Positive Regulation Of Cell Communication Positive Regulation Of Signaling Positive Regulation Of Signal Transduction Regulation Of Cell Communication Regulation Of Signaling Positive Regulation Of Intracellular Signal Transduction Regulation Of Epithelial Cell Proliferation Cell Differentiation Positive Regulation Of MAPK Cascade Cell Surface Receptor Signaling Pathway Cellular Developmental Process Cell Population Proliferation Regulation Of Cell Cycle Regulation Of Locomotion Neurogenesis Intracellular Signal Transduction Negative Regulation Of Signaling Regulation Of Cell Motility Negative Regulation Of Cell Communication Growth Factor Activity Negative Regulation Of Signal Transduction Regulation Of Cell Migration Regulation Of Programmed Cell Death Fibroblast Growth Factor Receptor Binding Intracellular Signaling Cassette Animal Organ Development Regulation Of Apoptotic Process Developmental Process Regulation Of Developmental Process Negative Regulation Of Programmed Cell Death Negative Regulation Of Apoptotic Process Positive Regulation Of Epithelial Cell Proliferation Regulation Of Phosphorus Metabolic Process Regulation Of Cell Cycle Phase Transition Protein Kinase Binding Epithelial Cell Proliferation Regulation Of Cell Differentiation Regulation Of ERK1 And ERK2 Cascade MAPK Cascade Positive Regulation Of Macromolecule Metabolic Process Positive Regulation Of Metabolic Process	Nucleus Nucleoplasm Cellular Response To Stress Regulation Of Cell Cycle Regulation Of Primary Metabolic Process DNA Damage Response Regulation Of Cell Population Proliferation Response To Stress Regulation Of Metabolic Process Positive Regulation Of Macromolecule Metabolic Process Regulation Of Macromolecule Metabolic Process Regulation Of Cell Cycle Process Positive Regulation Of Metabolic Process Regulation Of Cell Cycle Phase Transition Regulation Of Protein Stability Regulation Of Nucleobase-containing Compound Metabolic Process Positive Regulation Of Cell Population Proliferation Negative Regulation Of Metabolic Process Cytosol Regulation Of DNA Metabolic Process Regulation Of Protein Metabolic Process Response To Radiation Cytoplasm Positive Regulation Of Nucleobase-containing Compound Metabolic Process DNA Replication Initiation Positive Regulation Of Macromolecule Biosynthetic Process Regulation Of Mitotic Cell Cycle DNA Metabolic Process Positive Regulation Of Biosynthetic Process Nucleotide Binding Regulation Of Cellular Component Organization Macromolecule Metabolic Process Protein-containing Complex Negative Regulation Of Macromolecule Metabolic Process Cellular Senescence ATP Binding Positive Regulation Of Cell Cycle Process Regulation Of Mitotic Cell Cycle Phase Transition Positive Regulation Of DNA-templated Transcription Positive Regulation Of RNA Biosynthetic Process Regulation Of Catalytic Activity Cellular Response To Radiation Positive Regulation Of Transcription By RNA Polymerase II Nucleic Acid Metabolic Process Positive Regulation Of Cell Cycle Phase Transition Protein Stabilization Regulation Of Signal Transduction By P53 Class Mediator Positive Regulation Of DNA Metabolic Process Positive Regulation Of Fibroblast Proliferation Nucleobase-containing Compound Metabolic Process
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?